# Kansas City Oncology Program IRB – FDA Inspection, Mar 15, 2018

Source: https://www.keypedia.com/records/fda_inspections/kansas-city-oncology-program-irb/e8b3303f-6973-4037-99cc-06b394230d0c
Source feed: FDA_Inspections

> FDA inspection 1044348 of Kansas City Oncology Program IRB, March 15, 2018. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 56. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1044348
- Company Name: Kansas City Oncology Program IRB
- Inspection Date: 2018-03-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 765489 - 2012-01-26](https://www.keypedia.com/records/fda_inspections/kansas-city-oncology-program-irb/4321be95-9813-41c7-8208-b814c4260a12)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/carmen-y-fisher/d41b9f1a-1a29-4b1c-bd64-acedde50302a)

Company: https://www.keypedia.com/companies/kansas-city-oncology-program-irb/a052de7f-204f-44bf-a213-081debcc5fab

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c